These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 508454)
1. Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease. Knight RK; Miall PA; Hawkins LA; Dacombe J; Edwards CR; Hamer J Br Heart J; 1979 Sep; 42(3):316-25. PubMed ID: 508454 [TBL] [Abstract][Full Text] [Related]
2. Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure. Nicholls MG; Espiner EA; Hughes H; Rogers T Br Heart J; 1976 Oct; 38(10):1025-30. PubMed ID: 973876 [TBL] [Abstract][Full Text] [Related]
3. Potassium depletion in severe heart disease. White RJ; Chamberlain DA; Hamer J; McAlister J; Hawkins LA Br Med J; 1969 Jun; 2(5657):606-10. PubMed ID: 5798471 [TBL] [Abstract][Full Text] [Related]
4. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782 [TBL] [Abstract][Full Text] [Related]
5. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin. Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668 [TBL] [Abstract][Full Text] [Related]
6. Potassium and sodium distribution in cardiac failure. Cox JR; Horrocks P; Speight CJ; Pearson RE; Hobson N Clin Sci; 1971 Jul; 41(1):55-61. PubMed ID: 4934401 [No Abstract] [Full Text] [Related]
7. Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists. Haschke F; Wimmer M; Parth K Padiatr Padol; 1981; 16(3):317-26. PubMed ID: 7254888 [TBL] [Abstract][Full Text] [Related]
8. Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension. Cleland JG; Dargie HJ; Robertson I; Robertson JI; East BW Br Heart J; 1987 Sep; 58(3):230-8. PubMed ID: 3311097 [TBL] [Abstract][Full Text] [Related]
9. Management of potassium problems during long-term diuretic therapy. Kosman ME JAMA; 1974 Nov; 230(5):743-8. PubMed ID: 4479242 [No Abstract] [Full Text] [Related]
10. [Use of aldactone-saltucine in patients with heart failure]. Bobkova VI; Kartitskií VS; Lapkes TG; Mazurova SV Kardiologiia; 1975 May; 15(5):105-8. PubMed ID: 1152318 [TBL] [Abstract][Full Text] [Related]
11. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Bayliss J; Norell M; Canepa-Anson R; Sutton G; Poole-Wilson P Br Heart J; 1987 Jan; 57(1):17-22. PubMed ID: 3541995 [TBL] [Abstract][Full Text] [Related]
12. Effects of aldosterone on intralymphocytic sodium and potassium in patients with primary aldosteronism. Wehling M; Kuhls S; Witzgall H; Kuhnle U; Armanini D; Theisen K Acta Endocrinol (Copenh); 1987 Dec; 116(4):555-60. PubMed ID: 3425166 [TBL] [Abstract][Full Text] [Related]
13. [Clinical use of concurrent antagonists of aldosterone in patients with cardiac insufficiency]. Smolenskiĭ VS; Gel'fond MB; Khodzhamirov VS; Samosiuk IM Kardiologiia; 1969 Jun; 9(6):13-9. PubMed ID: 5806633 [No Abstract] [Full Text] [Related]
14. Intracellular electrolytes in cardiac failure. Wester PO; Dyckner T Acta Med Scand Suppl; 1986; 707():33-6. PubMed ID: 3017056 [TBL] [Abstract][Full Text] [Related]
15. In situ demonstration of angiotensin-dependent and independent pathways for hyperaldosteronism during chronic extracellular fluid volume depletion. Takaya J; Matsusaka T; Katori H; Tamura M; Miyazaki Y; Homma T; Ichikawa I Mol Endocrinol; 2001 Dec; 15(12):2229-35. PubMed ID: 11731622 [TBL] [Abstract][Full Text] [Related]
16. Intracellular electrolyte depletion in patients with ileostomies. Turnberg LA; Morris AI; Hawker PC; Herman KJ; Shields RA; Horth CE Gut; 1978 Jun; 19(6):563-8. PubMed ID: 680590 [TBL] [Abstract][Full Text] [Related]
17. [ON THE MECHANISM OF ACTION OF THE DIURETIC ACTIVITY OF 2,4,7-TRIAMINO-6-PHENYL-PTERIDINE (TRIAMTERENE)]. RUBEGNI M; RAVENNI G; FORCONI S Minerva Med; 1963 Sep; 54():2687-9. PubMed ID: 14094509 [No Abstract] [Full Text] [Related]
18. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure. Rademaker MT; Charles CJ; Nicholls MG; Richards AM Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy. Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601 [TBL] [Abstract][Full Text] [Related]
20. Combination diuretic treatment in severe heart failure: a randomised controlled trial. Channer KS; McLean KA; Lawson-Matthew P; Richardson M Br Heart J; 1994 Feb; 71(2):146-50. PubMed ID: 8130022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]